2021-11-15T23:23:16-06:00 2020-12-31 New York-Hurricane Ida Foundation Source One Hollow Ln Ste 212 Lake Success NY 11042 990PF 2020-01-01 454797578 David & Janet Polak Foundation % Jeff Polak DAVI 8008391754 Foundation Source 501 Silverside Rd Wilmington DE 198091377 Jeff Polak President 8008391754 2021-11-15 true Jeff Polak 999009999 Jeffrey D Haskell P01345770 8008391754 2020 2022-09-23 18:48:47Z X 77927007 X 0 X 66750 66750 887181 887181 1647887 28649648 1468254 634921 555329 3236739 2977514 222800 222800 210000 210000 40707 40707 16907 0 0 16907 418029 386250 31779 49530 49530 195674 28110 24502 24502 404 404 626699 471610 98164 1805252 935500 0 645263 2755032 2755032 4560284 935500 0 3400295 -1323545 2042014 13205819 3036171 3036171 24269959 33783681 34150982 10626824 9776068 12635157 20967644 21159666 24922961 3342999 3342999 3181736 72413245 71098585 77927007 0 0 X 72413245 71098585 72413245 71098585 72413245 71098585 72413245 -1323545 8885 71098585 71098585 Publicly-traded Securities 24661274 23456233 1205041 1205041 Passthrough K1 Capital Gain/(Loss) 222117 1150 UNION INVESTORS LLC P 2016-05-31 2020-06-25 7593 7593 LATITUDE MGMT RE CAPITAL III INC P 2013-05-23 2020-06-01 125000 125000 LATITUDE MGMT RE CAPITAL III INC P 2013-05-23 2020-07-21 100000 100000 LATITUDE MGMT RE CAPITAL III INC P 2020-09-15 75000 75000 LATITUDE MGMT RE CAPITAL III INC P 2013-10-15 2020-10-15 50000 50000 LATITUDE MGMT RE CAPITAL III INC P 2020-11-16 75000 75000 LATITUDE MGMT RE CAPITAL III INC P 2014-05-14 2020-12-16 25000 25000 TRINITY CAPITAL FUND III, L.P P 2017-12-13 2020-01-16 3530781 3530775 6 6 DISTRIBUTIONS IN EXCESS OF BASIS 41090 1468254 28384 28384 28384 85336 0 85336 X 56952 28400 28552 false false false false false true true false true true CA DE true false false false false true Jeff Polak 3106014296 1725 Green Acres Beverly Hills CA 90210 false false false true true false false false false false false false false false false false false false false false false false David Polak Foundation Source 501 Silverside Rd Wilmington DE 198091377 Dir 1.0 0 0 0 Janet Polak Foundation Source 501 Silverside Rd Wilmington DE 198091377 Dir 1.0 0 0 0 Jeff Polak Foundation Source 501 Silverside Rd Wilmington DE 198091377 Dir, Pres, executive dir 40.0 222800 11000 0 Robert Polak Foundation Source 501 Silverside Rd Wilmington DE 198091377 Dir 1.0 0 0 0 Jonathan Seltzer Foundation Source 501 Silverside Rd Wilmington DE 198091377 Dir 1.0 0 0 0 Noreen L Rubio 4301 MANDALAY DRIVE LOS ANGELES CA 90063 ADMINISTRATIVE ASST 40.0 60000 Karen Springer PO BOX 574 PALO ALTO CA 94302 PROGRAM ADVISOR 40.0 150000 0 Polak Investors LLC 1880 Century Park East Suite 811 Los Angeles CA 90067 Investment Mgmt 374402 Foundation Source 55 Walls Drive 3rd Fl Fairfield CT 06824 Administrative 86452 42953189 8850476 24578787 76382452 0 76382452 1145737 75236715 3761836 3761836 28384 34963 63347 3698489 8885 3707374 3707374 3400295 0 0 0 0 3400295 0 3400295 3707374 3339727 2018 2017 2016 3400295 3339727 60568 0 0 3646806 0 0 NONE X AMCHA INITIATIVE 517 BETHANY CURVE SANTA CRUZ CA 95060 N/A PC General & Unrestricted 30000 AMERICAN FRIENDS OF ISRAELI NAVY SEALS INC 138 W 133RD ST NEW YORK NY 10030 N/A PC scholarship fund to four candidates 21000 AMERICAN SOCIETY FOR TECHNION- ISRAEL INSTITUTE OF 55 EAST 59TH ST NEW YORK NY 10022 N/A PC the David & Janet Polak Family Distance learning studio fund 1000000 AMERICAN SOCIETY FOR TECHNION- ISRAEL INSTITUTE OF 55 EAST 59TH ST NEW YORK NY 10022 N/A PC General & Unrestricted 5000 AMERICANS FOR BEN-GURION UNIVERSITY INC 1001 AVE OF THE AMERICAS FL 19 NEW YORK NY 10018 N/A PC General & Unrestricted 20000 ASSOCIATION FOR THE STUDY OF THE MIDDLE EAST AND A PO BOX 2241 BALA CYNWYD PA 19004 N/A PC General & Unrestricted 5000 AYN RAND INSTITUTE THE CENTER FOR THE ADVANCEMENT 6 HUTTON CENTRE DR STE 600 SANTA ANA CA 92707 N/A PC the Free Books to Teacher program: distribution of books throughout the Los Angeles area 25000 AYN RAND INSTITUTE THE CENTER FOR THE ADVANCEMENT 6 HUTTON CENTRE DR STE 600 SANTA ANA CA 92707 N/A PC ARC Israel fund 10000 BEIT TSHUVAH 8831 VENICE BLVD LOS ANGELES CA 90034 N/A PC General & Unrestricted 1500 BUCKLEY SCHOOL 3900 STANSBURY AVE SHERMAN OAKS CA 91423 N/A PC General & Unrestricted 7500 CEDARS-SINAI MEDICAL CENTER 8700 BEVERLY BLVD W HOLLYWOOD CA 90048 N/A PC the Polak Family Fellowship fund in Precision Healthcare, board of governors innovation center 100000 CEDARS-SINAI MEDICAL CENTER 8700 BEVERLY BLVD W HOLLYWOOD CA 90048 N/A PC General & Unrestricted 25000 CENTRAL FUND OF ISRAEL 461 CENTRAL AVE CEDARHURST NY 11516 N/A PC Palestinian Media Watch fund 25000 COMMITTEE FOR ACCURACY IN MIDDLE EAST REPORTING IN PO BOX 35040 BOSTON MA 02135 N/A PC General & Unrestricted 10000 CONCERN FOUNDATION 11111 W OLYMPIC BLVD STE 214 LOS ANGELES CA 90064 N/A PC General & Unrestricted 6000 CUFI CHURCH ASSOCIATION PO BOX 1307 SAN ANTONIO TX 78295 N/A PC General & Unrestricted 10000 DAVID HOROWITZ FREEDOM CENTER 14724 VENTURA BLVD STE 820 SHERMAN OAKS CA 91403 N/A PC General & Unrestricted 10000 ENDOWMENT FOR MIDDLE EAST TRUTH 700 STONINGTON RD SILVER SPRING MD 20902 N/A PC General & Unrestricted 10000 FOUNDATION FOR INDIVIDUAL RIGHTS IN EDUCATION INC 510 WALNUT ST STE 1250 PHILADELPHIA PA 19106 N/A PC General & Unrestricted 5000 FRIENDS OF ELNET 5215 OLD ORCHARD RD STE 880 SKOKIE IL 60077 N/A PC General & Unrestricted 30000 FRIENDS OF SHEBA MEDICAL CENTER INC 6505 WILSHIRE BLVD NO 615 LOS ANGELES CA 90048 N/A PC General & Unrestricted 5000 FRIENDS OF THE ISRAEL DEFENSE FORCES 60 E 42ND ST NEW YORK NY 10165 N/A PC IMPACT! Scholarship fund 48000 FRIENDS OF THE ISRAEL DEFENSE FORCES - LOS ANGELES 6505 WILSHIRE BLVD STE 625 LOS ANGELES CA 90048 N/A PC IMPACT! Scholarship fund 52000 HAROLD GRINSPOON FOUNDATION 67 HUNT ST STE 100 AGAWAM MA 01001 N/A SO I pj library program book fund in domestic and international communities 91112 HILLCREST COUNTRY CLUB CHARITABLE FUND 10000 W PICO BLVD LOS ANGELES CA 90064 N/A PC General & Unrestricted 5000 HONEST REPORTING COM INC 165 E 56TH ST 2ND FL NEW YORK NY 10022 N/A PC General & Unrestricted 3000 IMERMAN ANGELS 205 W RANDOLPH ST 19TH FL CHICAGO IL 60606 N/A PC General & Unrestricted 5000 INVEST FOR KIDS INC 875 N MICHIGAN AVE STE 3400 CHICAGO IL 60611 N/A PC General & Unrestricted 5000 ISRAEL CANCER RESEARCH FUND INC 52 VANDERBILT AVE S1510 NEW YORK NY 10017 N/A PC General & Unrestricted 5000 ISRAEL CHRISTIAN NEXUS 11039 MCCORMICK ST N HOLLYWOOD CA 91601 N/A PC General & Unrestricted 1000 ISRAEL EMERGENCY ALLIANCE - STANDWITHUS PO BOX 341069 LOS ANGELES CA 90034 N/A PC General & Unrestricted 200000 ISRAEL TENNIS CENTERS FOUNDATION INC 57 W 38TH ST STE 605 NEW YORK NY 10018 N/A PC General & Unrestricted 3600 JEWBELONG INC PO BOX 3013 UPR MONTCLAIR NJ 07043 N/A PC General & Unrestricted 5000 JEWISH FEDERATION COUNCIL OF GREATER LOS ANGELES 6505 WILSHIRE BLVD STE 800 LOS ANGELES CA 90048 N/A PC General & Unrestricted 45000 JEWISH FEDERATION COUNCIL OF GREATER LOS ANGELES 6505 WILSHIRE BLVD STE 800 LOS ANGELES CA 90048 N/A PC the Guard Force program to expand current Community security efforts, development and launch of a computer-based training program of advanced situational awareness 75000 JEWISH FEDERATION COUNCIL OF GREATER LOS ANGELES 6505 WILSHIRE BLVD STE 800 LOS ANGELES CA 90048 N/A PC PJ Library Program books fund 18000 LAWFARE PROJECT INC 633 3RD AVE FL 21 NEW YORK NY 10017 N/A PC General & Unrestricted 30000 LOS ANGELES JEWISH HOME FOR THE AGING 7150 TAMPA AVE RESEDA CA 91335 N/A PC General & Unrestricted 25000 MAKE A WISH FOUNDATION OF GREATER LOS ANGELES 11390 W OLYMPIC BLVD STE 300 LOS ANGELES CA 90064 N/A PC General & Unrestricted 10000 MANHATTAN INSTITUTE FOR POLICY RESEARCH INC 52 VANDERBILT AVE NEW YORK NY 10017 N/A PC General & Unrestricted 5000 MASSACHUSETTS INSTITUTE OF TECHNOLOGY 600 MEMORIAL DR BLDG W98-300 CAMBRIDGE MA 02139 N/A PC General & Unrestricted 10000 MIDDLE EAST FORUM 1650 MARKET ST STE 3600 PHILADELPHIA PA 19103 N/A PC annual Israel victory project 40000 MIDDLE EAST MEDIA AND RESEARCH INSTITUTE INC PO BOX 27837 WASHINGTON DC 20038 N/A PC General & Unrestricted 20000 MOISHE HOUSE 441 SAXONY RD NO BARN 2 ENCINITAS CA 92024 N/A PC community building fund in Los Angeles 45000 PACIFIC LEGAL FOUNDATION 555 CAPITOL MALL STE 1290 SACRAMENTO CA 95814 N/A PC General & Unrestricted 5000 PRAGER UNIVERSITY FOUNDATION 15021 VENTURA BLVD 552 SHERMAN OAKS CA 91403 N/A PC General & Unrestricted 100000 PROCLAIMING JUSTICE TO THE NATIONS INC PO BOX 682711 FRANKLIN TN 37068 N/A PC General & Unrestricted 30000 REPORT INC - RESEARCH EVALUATION PROMOTING OR PMB 225 1121 N BETHLEHEM PIKE STE 6 SPRING HOUSE PA 19477 N/A PC General & Unrestricted 30000 SIMON WIESENTHAL CENTER INC 1399 S ROXBURY 2ND FL LOS ANGELES CA 90035 N/A PC Moriah Films' comprehensive documentary about the life and legacy of david ben-gurion project 70000 STUDENTS RUN AMERICA 5252 CREBS AVE TARZANA CA 91356 N/A PC General & Unrestricted 5000 THE JEWISH HOME AND SENIOR LIVING FOUNDATION 302 SILVER AVE SAN FRANCISCO CA 94112 N/A PC the Emergency Covid19 Response Program 10000 THE JEWISH INSTITUTE FOR NATIONAL SECURITY OF AMER 1101 14TH ST NW STE 1030 WASHINGTON DC 20005 N/A PC The Fight Against the Conditioning of Military Aid to israel project 134820 THE JEWISH INSTITUTE FOR NATIONAL SECURITY OF AMER 1101 14TH ST NW STE 1030 WASHINGTON DC 20005 N/A PC General & Unrestricted 10000 THE MAPLE COUNSELING CENTER 439 N CANON DR STE 209 BEVERLY HILLS CA 90210 N/A PC General & Unrestricted 2500 TRIBE MEDIA CORP 3250 WILSHIRE BLVD STE 1250 LOS ANGELES CA 90010 N/A PC General & Unrestricted 65000 TURNING POINT USA INC 4940 EAST BEVERLY RD PHOENIX AZ 85044 N/A PC General & Unrestricted 50000 UNIVERSITY OF SOUTHERN CALIFORNIA 1150 S OLIVE ST 25TH FL LOS ANGELES CA 90015 N/A PC Technion|USC Postdoctoral Fellowship fund 80000 WASHINGTON INSTITUTE FOR NEAR EAST POLICY 1111 19TH ST NW STE 500 WASHINGTON DC 20036 N/A PC General & Unrestricted 5000 YOUNG AMERICA'S FOUNDATION 11480 COMMERCE PARK DR STE 600 RESTON VA 20191 N/A PC to reach broader youth audiences through the campaign to drive up and maximize views for ben shapiro's top lectures on youtube 50000 2755032 14 66750 14 887181 525990 240117 18 1407770 K-1 Inc/Loss 525990 38427 14 559221 Federal Tax Refund 01 37273 278544 2958195 3236739 false false false false false false false false false false Jeff Polak * david polak (director), Janet polak (director) and jeff POLAK PRESIDENT/DIRECTOR/EXECUTIVE DIRECTOR), OF DAVID & JANET POLAK FOUNDATION (THE "FOUNDATION"), ARE PRINCIPALS AT THE INVESTMENT MANAGEMENT FIRM POLAK INVESTORS, LLC, A DISQUALIFIED PERSON WHICH PROVIDES INVESTMENT MANAGEMENT SERVICES TO THE FOUNDATION. IN THE TAXABLE YEAR ENDING DECEMBER 31, 2020, THE FOUNDATION PAID $374,402 FOR INVESTMENT MANAGEMENT SERVICES RENDERED BY SUCH DISQUALIFIED PERSON, AS REPORTED IN PART I, Line 16c. THE REASONABLENESS OF THE PROFESSIONAL FEES WAS ESTABLISHED BY AN OUTSIDE COMPENSATION COMMITTEE, WHICH REVIEWED THE RATES CHARGED BY COMPARABLE INVESTMENT MANAGEMENT FIRMS. NeuroVision Imaging LLC 1395 Garden Highway Suite 250 Sacramento CA 95833 2014-12-17 250000 PRI INVEST-SEE GENERAL EXPLANATION FOR ADDITIONAL INFORMATION NO See General Explanation for Report Dates The grantor has no reason to doubt the accuracy or reliability of the reports from the grantee; therefore, no independent verification of the reports were made. Bruin Biometrics LLC 10960 Wilshire Blvd Suite 950 Los Angeles CA 90024 2015-05-13 250000 PRI INVEST-SEE GENERAL EXPLANATION FOR PURPOSE & ADDTL DETAILS RE AMT EXPENDED & LACK OF DIVERSION NO See General Explanation for Report Dates The grantor has no reason to doubt the accuracy or reliability of the reports from the grantee; therefore, no independent verification of the reports were made. Biop Medical LTD 10 Haeliav St Ramat Gan IS 5252263 2017-04-21 250000 PRI INVEST-SEE GENERAL EXPLANATION FOR PURPOSE & ADDTL DETAILS RE AMT EXPENDED & LACK OF DIVERSION NO See General Explanation for Report Dates The grantor has no reason to doubt the accuracy or reliability of the reports from the grantee; therefore, no independent verification of the reports were made. Online Disruptive Technologies Inc MATAM Adv Tech Pk bld 23 pobx 15050 haifa IS 3190501 2017-04-21 250000 PRI INVEST-SEE GENERAL EXPLANATION FOR PURPOSE & ADDTL DETAILS RE AMT EXPENDED & LACK OF DIVERSION NO See General Explanation for Report Dates The grantor has no reason to doubt the accuracy or reliability of the reports from the grantee; therefore, no independent verification of the reports were made. Orgenesis Ltd Arad Street 9 Tel Aviv IS 2017-04-21 305498 PRI INVEST-SEE GENERAL EXPLANATION FOR PURPOSE & ADDTL DETAILS RE AMT EXPENDED & LACK OF DIVERSION NO See General Explanation for Report Dates The grantor has no reason to doubt the accuracy or reliability of the reports from the grantee; therefore, no independent verification of the reports were made. Bryn Pharma LLC fka EPI-Now LLC 518 North Hillcrest Road Beverly Hills CA 90210 2018-07-13 250000 PRI INVEST-SEE GENERAL EXPLANATION FOR PURPOSE & ADDTL DETAILS RE AMT EXPENDED & LACK OF DIVERSION NO See General Explanation for Report Dates The grantor has no reason to doubt the accuracy or reliability of the reports from the grantee; therefore, no independent verification of the reports were made. CyWat Technologies Ltd 168 Jabotinsky St Bnei Brak IS 2018-11-26 250000 PRI INVEST-SEE GENERAL EXPLANATION FOR PURPOSE & ADDTL DETAILS RE AMT EXPENDED & LACK OF DIVERSION NO See General Explanation for Report Dates The grantor has no reason to doubt the accuracy or reliability of the reports from the grantee; therefore, no independent verification of the reports were made. Y&B Mothers Choice Ltd HiTech Vil 4/9 givat ram POB 39231 jerusalem IS 9129102 2018-04-20 250000 PRI INVEST-SEE GENERAL EXPLANATION FOR PURPOSE & ADDTL DETAILS RE AMT EXPENDED & LACK OF DIVERSION NO See General Explanation for Report Dates The grantor has no reason to doubt the accuracy or reliability of the reports from the grantee; therefore, no independent verification of the reports were made. Y&B Mothers Choice Ltd HiTech Vil 4/9 givat ram POB 39231 Jerusalem IS 9129102 2018-07-19 250000 PRI INVEST-SEE GENERAL EXPLANATION FOR PURPOSE & ADDTL DETAILS RE AMT EXPENDED & LACK OF DIVERSION NO See General Explanation for Report Dates The grantor has no reason to doubt the accuracy or reliability of the reports from the grantee; therefore, no independent verification of the reports were made. MaxQ AI Ltd 96 Yigal Alon Street Entrance A Tel Aviv IS 6789140 2019-03-19 250000 PRI INVEST-SEE GENERAL EXPLANATION FOR PURPOSE & ADDTL DETAILS RE AMT EXPENDED & LACK OF DIVERSION NO The grantor has no reason to doubt the accuracy or reliability of the reports from the grantee; therefore, no independent verification of the reports were made. ExThera Medical Corporation 757 Arnold Drive Suite B Martinez CA 94553 2019-12-19 250000 PRI INVEST-SEE GENERAL EXPLANATION FOR PURPOSE & ADDTL DETAILS RE AMT EXPENDED & LACK OF DIVERSION NO See General Explanation for Report Dates The grantor has no reason to doubt the accuracy or reliability of the report from the grantee; therefore, no independent verification of the report was made. YonaLink Ltd Hadassah Ein Kerem Hosp POB 12000 Jerusalem IS 9112001 2019-11-12 250000 PRI INVEST-SEE GENERAL EXPLANATION FOR PURPOSE & ADDTL DETAILS RE AMT EXPENDED & LACK OF DIVERSION NO See General Explanation for Report Dates The grantor has no reason to doubt the accuracy or reliability of the report from the grantee; therefore, no independent verification of the report was made. Amicrobe Inc 3142 Tiger Run Court 103 Carlsbad CA 92010 2019-10-31 250000 PRI INVEST-SEE GENERAL EXPLANATION FOR PURPOSE & ADDTL DETAILS RE AMT EXPENDED & LACK OF DIVERSION NO See General Explanation for Report Dates The grantor has no reason to doubt the accuracy or reliability of the report from the grantee; therefore, no independent verification of the report was made. FORM 990-PF, PART VII-B, LINE 5C - EXPENDITURE RESPONSIBILITY FORM 990-PF, PART VII-B, LINE 5C - EXPENDITURE RESPONSIBILITY PRI RECIPIENT: NeuroVision Imaging, LLC DATES AND AMOUNTS OF PRI: 12/17/2014 $250,000 5/17/2018 $37,502 PURPOSE OF PRI: Research and development of diagnostic tools for early-stage detection of Alzheimer's disease and other degenerative neurological disorders. REPORTS OF AMOUNTS EXPENDED: RECIPIENT HAS SUBMITTED FULL AND COMPLETE FINANCIAL REPORTS OF THE TYPE ORDINARILY REQUIRED BY COMMERCIAL INVESTORS UNDER SIMILAR CIRCUMSTANCES AND A STATEMENT THAT IT HAS COMPLIED WITH THE TERMS OF THE INVESTMENT FOR ITS FISCAL YEARS INDICATED BELOW: DATE OF REPORT: 3/25/2015 FOR FYE 12/31/2014 DATE OF REPORT: 5/18/2016 FOR FYE 12/31/2015 DATE OF REPORT: 6/7/2017 FOR FYE 12/31/2016 DATE OF REPORT: 5/11/2018 FOR FYE 12/31/2017 DATE OF REPORT: 11/1/2019 FOR FYE 12/31/2018 DATE OF REPORT: 6/2/2020 FOR FYE 12/31/2019 DATE OF REPORT: 6/28/2021 FOR FYE 12/31/2020 THIS INVESTMENT REMAINED ON THE FOUNDATION'S BOOKS AS OF 12/31/2020. DIVERSIONS: TO THE KNOWLEDGE OF THE GRANTOR, NO FUNDS HAVE BEEN DIVERTED TO ANY ACTIVITY OTHER THAN THE ACTIVITY FOR WHICH THE INVESTMENT WAS ORIGINALLY MADE. FORM 990-PF, PART VII-B, LINE 5C - EXPENDITURE RESPONSIBILITY FORM 990-PF, PART VII-B, LINE 5C - EXPENDITURE RESPONSIBILITY PRI RECIPIENT: BRUIN BIOMETRICS, LLC DATE AND AMOUNT OF PRI: 5/13/2015 $250,000 PURPOSE OF PRI: TO PROMOTE THE HEALTH AND REDUCE THE SUFFERING OF THOSE AFFECTED BY EARLY-STAGE PRESSURE ULCERS DURING THEIR HOSPITAL STAYS AND TO ADVANCE SCIENTIFIC UNDERSTANDING THROUGH RESEARCH IN THE PUBLIC INTEREST. REPORTS OF AMOUNTS EXPENDED: RECIPIENT HAS SUBMITTED A FULL AND COMPLETE FINANCIAL REPORTS OF THE TYPE ORDINARILY REQUIRED BY COMMERCIAL INVESTORS UNDER SIMILAR CIRCUMSTANCES AND A STATEMENT THAT IT HAS COMPLIED WITH THE TERMS OF THE INVESTMENT FOR ITS FISCAL YEARS INDICATED BELOW: DATE OF REPORT: 5/24/2016 FOR FYE 12/31/2015 DATE OF REPORT: 6/29/2017 FOR FYE 12/31/2016 DATE OF REPORT: 5/15/2018 FOR FYE 12/31/2017 DATE OF REPORT: 6/14/2019 FOR FYE 12/31/2018 DATE OF REPORT: 4/22/2020 FOR FYE 12/31/2019 THIS INVESTMENT REMAINED ON THE FOUNDATION'S BOOKS AS OF 12/31/2020. DIVERSIONS: TO THE KNOWLEDGE OF THE GRANTOR, NO FUNDS HAVE BEEN DIVERTED TO ANY ACTIVITY OTHER THAN THE ACTIVITY FOR WHICH THE INVESTMENT WAS ORIGINALLY MADE. FORM 990-PF, PART VII-B, LINE 5C - EXPENDITURE RESPONSIBILITY FORM 990-PF, PART VII-B, LINE 5C - EXPENDITURE RESPONSIBILITY PRI RECIPIENT: BIOP MEDICAL LTD DATES AND AMOUNTS OF PRI: 4/21/2017 $250,000 PURPOSE OF PRI: TO PROMOTE THE HEALTH AND REDUCE THE SUFFERING OF THOSE AFFECTED BY DISEASE AND TO ADVANCE SCIENTIFIC UNDERSTANDING THROUGH RESEARCH IN THE PUBLIC INTEREST. REPORTS OF AMOUNTS EXPENDED: RECIPIENT HAS SUBMITTED A FULL AND COMPLETE FINANCIAL REPORT OF THE TYPE ORDINARILY REQUIRED BY COMMERCIAL INVESTORS UNDER SIMILAR CIRCUMSTANCES AND A STATEMENT THAT IT HAS COMPLIED WITH THE TERMS OF THE INVESTMENT FOR ITS FISCAL YEARS INDICATED BELOW: DATE OF REPORT: 6/4/2018 FOR FYE 12/31/2017 DATE OF REPORT: 2/12/2019 FOR FYE 12/31/2018 THIS INVESTMENT REMAINED ON THE FOUNDATION'S BOOKS AS OF 12/31/2020. IN CONNECTION WITH THIS PROGRAM RELATED INVESTMENT ("PRI"), THE FOUNDATION HAS MADE NUMEROUS GOOD FAITH ATTEMPTS TO CONTACT THE INVESTEE AND REQUEST THE OVERDUE ANNUAL REPORTS FROM THE INVESTEE WITH RESPECT TO THE PRI, WHICH ATTEMPTS HAVE BEEN DOCUMENTED BY THE FOUNDATION, BUT HAS NOT BEEN ABLE TO OBTAIN SUCH REPORTS. PER SECTION 53.4945-5(E)(2) OF THE TREASURY REGULATIONS, THE FAILURE OF THE INVESTEE TO SUBMIT SUCH REPORTS WILL NOT RESULT IN A TAXABLE EXPENDITURE FOR THE FOUNDATION BECAUSE THE FOUNDATION (I) MADE THE PRI IN ACCORDANCE WITH PARAGRAPH (B) OF SAID SECTION OF THE REGULATIONS, (II) HAS COMPLIED WITH THE REPORTING REQUIREMENTS CONTAINED IN PARAGRAPH (D) OF SAID SECTION OF THE REGULATIONS, (III) MADE A REASONABLE EFFORT TO OBTAIN THE REQUIRED REPORTS, AND (IV) WILL WITHHOLD ALL FUTURE PRI PAYMENTS TO THE INVESTEE UNTIL SUCH REPORT IS FURNISHED. DIVERSIONS: TO THE KNOWLEDGE OF THE GRANTOR, NO FUNDS HAVE BEEN DIVERTED TO ANY ACTIVITY OTHER THAN THE ACTIVITY FOR WHICH THE INVESTMENT WAS ORIGINALLY MADE. FORM 990-PF, PART VII-B, LINE 5C - EXPENDITURE RESPONSIBILITY FORM 990-PF, PART VII-B, LINE 5C - EXPENDITURE RESPONSIBILITY PRI RECIPIENT: ONLINE DISRUPTIVE TECHNOLOGIES, INC. DATE AND AMOUNT OF PRI: 4/21/2017 $250,000 PURPOSE OF PRI: TO PROMOTE THE HEALTH AND REDUCE THE SUFFERING OF THOSE AFFECTED BY CANCER AND TO ADVANCE SCIENTIFIC UNDERSTANDING THROUGH RESEARCH IN THE PUBLIC INTEREST. REPORTS OF AMOUNTS EXPENDED: RECIPIENT HAS SUBMITTED A FULL AND COMPLETE FINANCIAL REPORT OF THE TYPE ORDINARILY REQUIRED BY COMMERCIAL INVESTORS UNDER SIMILAR CIRCUMSTANCES AND A STATEMENT THAT IT HAS COMPLIED WITH THE TERMS OF THE INVESTMENT FOR ITS FISCAL YEARS INDICATED BELOW: DATE OF REPORT: 6/6/2018 FOR FYE 12/31/2017 DATE OF REPORT: 2/12/2019 FOR FYE 12/31/2018 DATE OF REPORT: 6/1/2020 FOR FYE 12/31/2019 DATE OF REPORT: 8/18/2021 FOR FYE 12/31/2020 THIS INVESTMENT REMAINED ON THE FOUNDATION'S BOOKS AS OF 12/31/2020. DIVERSIONS: TO THE KNOWLEDGE OF THE GRANTOR, NO FUNDS HAVE BEEN DIVERTED TO ANY ACTIVITY OTHER THAN THE ACTIVITY FOR WHICH THE INVESTMENT WAS ORIGINALLY MADE. FORM 990-PF, PART VII-B, LINE 5C - EXPENDITURE RESPONSIBILITY FORM 990-PF, PART VII-B, LINE 5C - EXPENDITURE RESPONSIBILITY PRI RECIPIENT: Bryn Pharma LLC f/k/a EPI-Now LLC DATE AND AMOUNT OF PRI: 7/13/2018 $250,000 PURPOSE OF PRI: To promote the health of those who require epinephrine and to advance scientific understanding through research in the public interest. REPORTS OF AMOUNTS EXPENDED: RECIPIENT HAS SUBMITTED A FULL AND COMPLETE FINANCIAL REPORT OF THE TYPE ORDINARILY REQUIRED BY COMMERCIAL INVESTORS UNDER SIMILAR CIRCUMSTANCES AND A STATEMENT THAT IT HAS COMPLIED WITH THE TERMS OF THE INVESTMENT FOR ITS FISCAL YEARS INDICATED BELOW: DATE OF REPORT: 8/23/2019 FOR FYE 12/31/2018 DATE OF REPORT: 10/24/2020 FOR FYE 12/31/2019 DATE OF REPORT: 8/2/2021 FOR FYE 12/21/2020 THIS INVESTMENT REMAINED ON THE FOUNDATION'S BOOKS AS OF 12/31/2020. DIVERSIONS: TO THE KNOWLEDGE OF THE GRANTOR, NO FUNDS HAVE BEEN DIVERTED TO ANY ACTIVITY OTHER THAN THE ACTIVITY FOR WHICH THE INVESTMENT WAS ORIGINALLY MADE. appreciation of property. FORM 990-PF, PART VII-B, LINE 5C - EXPENDITURE RESPONSIBILITY FORM 990-PF, PART VII-B, LINE 5C - EXPENDITURE RESPONSIBILITY PRI RECIPIENT: Orgenesis Ltd. DATE AND AMOUNT OF PRI: 4/21/2017 $305,498 PURPOSE OF PRI: To promote the health and reduce the suffering of those affected by diabetes by way of researching and bringing to clinical trial the Company technology solution. REPORTS OF AMOUNTS EXPENDED: RECIPIENT HAS SUBMITTED FULL AND COMPLETE FINANCIAL REPORTS OF THE TYPE ORDINARILY REQUIRED BY COMMERCIAL INVESTORS UNDER SIMILAR CIRCUMSTANCES AND A STATEMENT THAT IT HAS COMPLIED WITH THE TERMS OF THE INVESTMENT FOR ITS FISCAL YEARS INDICATED BELOW: DATE OF REPORT: 9/9/2018 FOR FYE 12/31/2017 DATE OF REPORT: 10/20/2020 FOR FYE 12/31/2018 DATE OF REPORT: 10/20/2020 FOR FYE 12/31/2019 DATE OF REPORT: 5/20/2021 FOR FYE 12/31/2020 THE FOUNDATION EXERCISED AN OPTION TO EXCHANGE ITS INTEREST IN THE INVESTEE FOR THE STOCK IN THE PARENT COMPANY OF THE INVESTED. THIS WAS DONE TO PRESERVE THE PRI AND NOT TO GENERATE INCOME OR FOR THE APPRECIATION OF PROPERTY. THIS INVESTMENT REMAINED ON THE FOUNDATION'S BOOKS AS OF 12/31/2020. DIVERSIONS: TO THE KNOWLEDGE OF THE GRANTOR, NO FUNDS HAVE BEEN DIVERTED TO ANY ACTIVITY OTHER THAN THE ACTIVITY FOR WHICH THE INVESTMENT WAS ORIGINALLY MADE. FORM 990-PF, PART VII-B, LINE 5C - EXPENDITURE RESPONSIBILITY FORM 990-PF, PART VII-B, LINE 5C - EXPENDITURE RESPONSIBILITY PRI RECIPIENT: CyWat Technologies Ltd DATE AND AMOUNT OF PRI: 11/26/2018 $250,000 PURPOSE OF PRI: To promote the health of people who are affected by polluted drinking water by funding the development of a water monitoring system that is distributed throughout the entire water grid and which can immediately detect potential dangers. REPORTS OF AMOUNTS EXPENDED: RECIPIENT HAS SUBMITTED A FULL AND COMPLETE FINANCIAL REPORT OF THE TYPE ORDINARILY REQUIRED BY COMMERCIAL INVESTORS UNDER SIMILAR CIRCUMSTANCES AND A STATEMENT THAT IT HAS COMPLIED WITH THE TERMS OF THE INVESTMENT FOR ITS FISCAL YEARS INDICATED BELOW: DATE OF REPORT: 6/18/2019 FOR FYE 12/31/2018 DATE OF REPORT: 1/13/2020 FOR FYE 12/31/2019 THIS INVESTMENT REMAINED ON THE FOUNDATION'S BOOKS AS OF 12/31/2020. DIVERSIONS: TO THE KNOWLEDGE OF THE GRANTOR, NO FUNDS HAVE BEEN DIVERTED TO ANY ACTIVITY OTHER THAN THE ACTIVITY FOR WHICH THE INVESTMENT WAS ORIGINALLY MADE. FORM 990-PF, PART VII-B, LINE 5C - EXPENDITURE RESPONSIBILITY FORM 990-PF, PART VII-B, LINE 5C - EXPENDITURE RESPONSIBILITY PRI RECIPIENT: Y&B MOTHERS CHOICE LTD. DATE AND AMOUNT OF PRI: 4/20/2018 $250,000 PURPOSE OF PRI: TO PROMOTE HEALTH BY FUNDING RESEARCH INTO DEVELOPING NON HAZARDOUS, NATURAL PRODUCTS THAT DO NOT ENDANGER HUMAN HEALTH. REPORTS OF AMOUNTS EXPENDED: RECIPIENT HAS SUBMITTED A FULL AND COMPLETE FINANCIAL REPORT OF THE TYPE ORDINARILY REQUIRED BY COMMERCIAL INVESTORS UNDER SIMILAR CIRCUMSTANCES AND A STATEMENT THAT IT HAS COMPLIED WITH THE TERMS OF THE INVESTMENT FOR ITS FISCAL YEARS INDICATED BELOW: DATE OF REPORT: 10/29/2020 FOR FYE 12/31/2018 DATE OF REPORT: 10/29/2020 FOR FYE 12/31/2019 THIS INVESTMENT REMAINED ON THE FOUNDATION'S BOOKS AS OF 12/31/2020. DIVERSIONS: TO THE KNOWLEDGE OF THE GRANTOR, NO FUNDS HAVE BEEN DIVERTED TO ANY ACTIVITY OTHER THAN THE ACTIVITY FOR WHICH THE INVESTMENT WAS ORIGINALLY MADE. PRI RECIPIENT: Y&B MOTHERS CHOICE LTD. DATE AND AMOUNT OF PRI: 7/19/2018 $250,000 PURPOSE OF PRI: TO PROMOTE HEALTH BY FUNDING RESEARCH INTO DEVELOPING NON HAZARDOUS, NATURAL PRODUCTS THAT DO NOT ENDANGER HUMAN HEALTH. REPORTS OF AMOUNTS EXPENDED: RECIPIENT HAS SUBMITTED A FULL AND COMPLETE FINANCIAL REPORT OF THE TYPE ORDINARILY REQUIRED BY COMMERCIAL INVESTORS UNDER SIMILAR CIRCUMSTANCES AND A STATEMENT THAT IT HAS COMPLIED WITH THE TERMS OF THE INVESTMENT FOR ITS FISCAL YEARS INDICATED BELOW: DATE OF REPORT: 10/29/2020 FOR FYE 12/31/2018 DATE OF REPORT: 10/29/2020 FOR FYE 12/31/2019 THIS INVESTMENT REMAINED ON THE FOUNDATION'S BOOKS AS OF 12/31/2020. DIVERSIONS: TO THE KNOWLEDGE OF THE GRANTOR, NO FUNDS HAVE BEEN DIVERTED TO ANY ACTIVITY OTHER THAN THE ACTIVITY FOR WHICH THE INVESTMENT WAS ORIGINALLY MADE. PRI RECIPIENT: MAXQ AI, LTD DATE OF PRI: 3/19/2019 $250,000 PURPOSE OF PRI: TO PROMOTE THE DEVELOPMENT OF A PRODUCT THAT WILL SUBSTANTIALLY BENEFIT THE PUBLIC BY INCORPORATING SOPHISTICATED ARTIFICIAL INTELLIGENCE INTO DIAGNOSTIC RADIOLOGY. REPORTS OF AMOUNTS EXPENDED: RECIPIENT HAS SUBMITTED A FULL AND COMPLETE FINANCIAL REPORT OF THE TYPE ORDINARILY REQUIRED BY COMMERCIAL INVESTORS UNDER SIMILAR CIRCUMSTANCES AND A STATEMENT THAT IT HAS COMPLIED WITH THE TERMS OF THE INVESTMENT FOR ITS FISCAL YEARS INDICATED BELOW: DATE OF REPORT: 10/13/2020 FOR FYE 12/31/2019 DATE OF REPORT: 7/20/2021 FOR FYE 12/31/2020 THIS INVESTMENT REMAINED ON THE FOUNDATION'S BOOKS AS OF 12/31/2020. DIVERSIONS: TO THE KNOWLEDGE OF THE GRANTOR, NO FUNDS HAVE BEEN DIVERTED TO ANY ACTIVITY OTHER THAN THE ACTIVITY FOR WHICH THE INVESTMENT WAS ORIGINALLY MADE. PRI RECIPIENT: EXTHERA MEDICAL CORPORATION DATE AND AMOUNT OF PRI: 12/19/2019 $250,000 PURPOSE OF PRI: TO FUND THE DEVELOPMENT AND/OR DISTRIBUTION OF CURRENT AND FUTURE MEDICAL TECHNOLOGY, INCLUDING WITHOUT LIMITATION THE SERAPH BLOOD FILTER DEVICE, THAT HAVE A DEMONSTRABLE DEMAND FOR HUMANITARIAN USE IN DEVELOPING COUNTRIES AND THAT OFFER BREAK-THROUGH TECHNOLOGY FOR USE IN THE TREATMENT OF INTRACTABLE OR EMERGING PUBLIC-HEALTH THREATS. REPORTS OF AMOUNTS EXPENDED: RECIPIENT HAS SUBMITTED A FULL AND COMPLETE FINANCIAL REPORT OF THE TYPE ORDINARILY REQUIRED BY COMMERCIAL INVESTORS UNDER SIMILAR CIRCUMSTANCES AND A STATEMENT THAT IT HAS COMPLIED WITH THE TERMS OF THE INVESTMENT FOR ITS FISCAL YEARS INDICATED BELOW: DATE OF REPORT: 2/2/2021 FOR FYE 12/31/2019 DATE OF REPORT: 6/30/2021 FOR FYE 12/31/2020 THIS INVESTMENT REMAINED ON THE FOUNDATION'S BOOKS AS OF 12/31/2020. DIVERSIONS: TO THE KNOWLEDGE OF THE GRANTOR, NO FUNDS HAVE BEEN DIVERTED TO ANY ACTIVITY OTHER THAN THE ACTIVITY FOR WHICH THE INVESTMENT WAS ORIGINALLY MADE. PRI RECIPIENT: YonaLink Ltd. DATE AND AMOUNT OF PRI: 11/12/2019 $250,000 PURPOSE OF PRI: To finance provision of the YonaLink Automated Study Manager Technology to nonprofit academic hospitals for free or at substantially below cost. The Technology has the potential to significantly improve the quality and efficiency of processing data for clinical research studies in the public interest. REPORTS OF AMOUNTS EXPENDED: RECIPIENT HAS SUBMITTED A FULL AND COMPLETE FINANCIAL REPORT OF THE TYPE ORDINARILY REQUIRED BY COMMERCIAL INVESTORS UNDER SIMILAR CIRCUMSTANCES AND A STATEMENT THAT IT HAS COMPLIED WITH THE TERMS OF THE INVESTMENT FOR ITS FISCAL YEARS INDICATED BELOW: DATE OF REPORT: 4/6/2021 FOR FYE 12/31/2019 THIS INVESTMENT REMAINED ON THE FOUNDATION'S BOOKS AS OF 12/31/2020. DIVERSIONS: TO THE KNOWLEDGE OF THE GRANTOR, NO FUNDS HAVE BEEN DIVERTED TO ANY ACTIVITY OTHER THAN THE ACTIVITY FOR WHICH THE INVESTMENT WAS ORIGINALLY MADE. PRI RECIPIENT: AMICROBE, INC. DATE AND AMOUNT OF PRI: 10/31/2019 $250,000 PURPOSE OF PRI: TO FUND THE DEVELOPMENT AND COMMERCIALIZATION OF AMICIDIN-ALPHA SURGICAL GEL AND ITS AMICIDIN-BETA SOLUTION, TOGETHER WITH RELATED WORK AND MEDICAL PRODUCTS HAVING SIMILAR PURPOSES. THIS HAS THE POTENTIAL TO PROVIDE BREAKTHROUGH TECHNOLOGICAL SOLUTIONS TO THE GROWING THREAT OF ANTIBIOTIC RESISTANCE AROUND THE WORLD. REPORTS OF AMOUNTS EXPENDED: RECIPIENT HAS SUBMITTED FULL AND COMPLETE FINANCIAL REPORTS OF THE TYPE ORDINARILY REQUIRED BY COMMERCIAL INVESTORS UNDER SIMILAR CIRCUMSTANCES AND A STATEMENT THAT IT HAS COMPLIED WITH THE TERMS OF THE INVESTMENT FOR ITS FISCAL YEARS INDICATED BELOW: DATE OF REPORT: 12/28/2020 FOR FYE 12/31/2019 DATE OF REPORT: 8/4/2021 FOR FYE 12/31/2020 THIS INVESTMENT REMAINED ON THE FOUNDATION'S BOOKS AS OF 12/31/2020. DIVERSIONS: TO THE KNOWLEDGE OF THE GRANTOR, NO FUNDS HAVE BEEN DIVERTED TO ANY ACTIVITY OTHER THAN THE ACTIVITY FOR WHICH THE INVESTMENT WAS ORIGINALLY MADE. Forms 8865 Forms 8865 The Foundation has prepared these forms to the best of its ability based on the limited information provided to it by the investment on which the Foundation is reporting and on the basis of having received no information to the contrary. Any missing or incomplete information is due to the Foundation's inability to obtain such information and is not a willful attempt to withhold such information. Part I line 6a PART I LINE 6A (990-PF) RECONCILIATION OF NET GAIN/(LOSS) FROM SALES OF ASSETS NOT INCLUDED IN PART IV TOTAL INCLUDED IN PART IV: (DETAILS BELOW) NET GAIN/(LOSS): $1,407,770 TOTAL NOT INCLUDED IN PART IV: PASSTHROUGH K-1 CAPITAL GAIN/(LOSS) - UBI NET GAIN/(LOSS): $240,117 TOTAL PART I, LINE 6A: $1,647,887 DETAILS OF ASSETS INCLUDED IN PART IV: PUBLICLY-TRAIDED SECURITIES GROSS SALES PRICE: $24,661,274 BOOK BASIS: $23,516,717 NET GAIN/(LOSS): $1,144,557 PASSTHROUGH K-1 CAPITAL GAIN/(LOSS) - NON UBI NET GAIN/(LOSS): $222,117 SALES OF OTHER ITEMIZED ASSETS GROSS SALES PRICE: $3,988,374 BOOK BASIS: $3,988,368 NET GAIN/(LOSS): $6 DISTRIBUTIONS IN EXCESS OF BASIS NET GAIN/(LOSS): $41,090 AMERICAN AXLE & MFG HOLDINGS I 251018 183480 B2 GOLD CORP COM NPV 150587 236320 BANK OF AMERICA CORP 113640 363720 BARRICK GOLD CORPORATION 768039 569500 BAYER A G SPONSORED ADR 198370 118720 BERRY PLASTICS GROUP INC 118805 168570 BP PLC SPONSORED ADR 102249 61560 CABOT OIL & GAS CORP 32348 32560 CAMECO CORPORATION 19784 13400 CHENIERE ENERGY INC 120095 120060 CITIGROUP INC 248049 308300 CLIFFS NATURAL RESOURCES INC. 50603 58240 COMPASS MINERALS INTERNATIONAL 253526 308600 COMSTOCK RES INC 18674 17480 CONSTELLIUM NV 136767 83940 COPPER MOUNTAIN MINI NG CORP 78225 198800 COVANTA HOLDING CORP 83405 65650 CROWN HOLDINGS INC 185100 501000 CVS CAREMARK CORP 466000 683000 DANA HOLDING CP 68217 97600 DELTA AIR LINES INC 24396 80420 ELDORADO GOLD CORP COM NPV 218701 238860 ENDEAVOUR MINING CORP 141284 162425 FIDELITY CONSERV INC BD FD 8564 8587 FIRST QUANTUM MINERALS LTD 17953 35940 FLUTTER ENTERTAINMENT ORD SHS 59804 91895 FTS INTERNATIONAL INC 321080 276826 GENERAL MOTORS 361740 416400 GOLD FIELDS LTD ADS 140581 241020 GOLDEN STAR RESOURCES LTD 13940 14840 GRAPHIC PACKAGING CORP COM STK 41828 50820 HALLIBURTON COMPANY 226736 113400 HOLCIM N 256612 283350 HUDBAY MINERALS INC 133864 175000 IVANHOE MINES LTD 60260 162000 JAPAN SMALLER CAPITALIZATION F 365092 414032 JET2 PLC 78926 195470 JOHNSON & JOHNSON 231728 393450 KAZATOMPROM JSC NAC GDR 147503 180000 KBR INC 91500 92790 KIRKLAND LAKE GOLD LTD 268643 338868 LAFARGEHOLCIM LTD ADR 67245 108400 MARKET VECTORS VIETNAM ETF 40705 34980 MERCK & CO INC 381120 654400 MICRON TECHNOLOGY 325144 902159 MICROSOFT CORP 28785 222420 NEWMONT GOLDCORP CORPORATION 574088 949615 NOVAGOLD RESOURCES 69977 174060 NUVEEN MLT STR I&G 9760 9500 OCEANAGOLD CORPORATION COM 103358 78400 PFIZER INC 490753 736200 PHILIP MORRIS INTL 8916 8279 PRETIUM RESOURCES INC 86644 114800 TEVA PHARMACEUTICAL INDUSTRIES 36513 9650 THE MOSAIC CO 169858 92040 TOREX GOLD RESOURCES 181332 225600 TPG RE FINANCE TRUST INC 2013 1062 TRUIST FINANCIAL CORPORATION 30848 47930 TURQUOISE HILL RESOURCES LTD 85140 62100 VALARIS PLC 382692 175 VIATRIS ORD SHS 26941 46494 30238616 30426972 3545065 3724010 AIR U.S. LIFE FUND III, LP 2020814 2011592 AIR US LIFE FUND IV, LP 2033480 2029825 ALTAIR - PACIFIC COAST CPTL PT 496156 592192 ALTAIR DIRECT LENDING FUND, LL 212783 173946 ALTAIR EUROPEAN R E OPPORTUNIT 659098 311089 ALTAIR SENIOR HOUSING FUND (AE 182992 740403 ANAGENESIS CAPITAL PARTNERS SB 897667 1037522 ASM CONNAUGHT HOUSE FUND III L 1000000 1172884 BROAD ST REAL ESTATE CREDIT PT 181145 BW GAS & CONVENIENCE ONSHORE F 424573 2379072 DORCHESTER CAPITAL SECONDARIES 188581 212717 ENLIGHTENMENT CAPITAL SOLUTION 984325 1624449 FALCON EDGE INDIA I LP 556167 701113 FIRST EAGLE CLO EQUITY FUND I, 834921 823393 FOURTHSTONE SMALL-CAP FINANCIA 251807 263874 GOLDMAN SACHS VINTAGE FUND V L 302066 142137 GRANITE CREEK FLEXCAP II, L.P 402725 480818 GS DISTRESSED OPPORTUNITIES FU 133187 157249 GSO CAPITAL SOLUTIONS FUND II 6463 6463 GSO CAPITAL SOLUTIONS FUND II 79926 63937 GSO CAPITAL SOLUTIONS FUND II 287336 124603 GSO ENERGY SELECT OPPORTUNITIE 272291 294771 GSO ENERGY SELECT OPPORTUNITIE 59065 59065 GSO ENERGY SELECT OPPORTUNITIE 1434 1434 GSO ENERGY SELECT OPPORTUNITIE 66759 40366 LATITUDE MGMT REAL ESTATE CAPI 500000 496683 LATITUDE MGMT REAL ESTATE CAPI 1500000 1502157 PCCP EQUITY VII, LP 2533796 3065724 PCCP EQUITY VIII, LP 556154 638614 SILVERPEAK CREDIT OPPORTUNITIE 263639 274117 SILVERPEAK CREDIT OPPORTUNITIE 1670998 1684065 THE EDGBASTON ASIAN EQUITY TRU 1249841 1104920 BERNIE L MADOFF - CLAIM RECEIV 530622 530622 General Consultations 16907 16907 PRI - AMICROBE, INC 250000 250000 PRI - BIOP MEDICAL 250000 250000 PRI - BRUIN_BIOMETRICS 250000 250000 PRI - BRYN PHARMA LLC F/K/A EP 250000 250000 PRI - CYWAT TECH 250000 250000 PRI - EXTHERA MEDICAL CORP 250000 250000 PRI - MAXQ AI, LTD 250000 250000 PRI - MOTHERS CHOICE 250000 250000 PRI - MOTHERS CHOICE (2) 250000 250000 PRI - ONLINE DISRUPTIVE 250000 250000 PRI - ORGENESIS - 32,052 SHARE 294397 144234 PRI - ORGENESIS WTS - 32,052 U 11100 PRI - SER A1 PFD (82,175 UNITS 250000 250000 PRI - SER A2 PFD (15,408 UNITS 37502 37502 PRI - YONALINK LTD 250000 250000 Administrative Fees 86452 86452 Bank Charges 8879 8879 K-1 Exp 1150 UNION INVESTORS L 4554 4554 K-1 Exp AIR U.S. LIFE FUND III 91232 91232 K-1 Exp AIR US LIFE FUND IV, L 30250 30250 K-1 Exp ALTAIR - PACIFIC COAST 19138 19017 K-1 Exp ALTAIR DIRECT LENDING 489 489 K-1 Exp ALTAIR SENIOR HOUSING 4125 2721 K-1 Exp ANAGENESIS CAPITAL PAR 132910 131625 K-1 Exp BW GAS & CONVENIENCE O 809 492 K-1 Exp ENLIGHTENMENT CAPITAL 34886 34886 K-1 Exp FALCON EDGE INDIA I LP 9168 9168 K-1 Exp FIRST EAGLE CLO EQUITY 22404 12436 K-1 Exp FOURTHSTONE SMALL-CAP 256 256 K-1 Exp GRANITE CREEK FLEXCAP 75426 75318 K-1 Exp GSO CAPITAL SOLUTIONS 7606 2264 K-1 Exp GSO CAPITAL SOLUTIONS 6899 6861 K-1 Exp GSO ENERGY SELECT OPPO 40973 4422 K-1 Exp GSO ENERGY SELECT OPPO 1326 926 K-1 Exp GSO ENERGY SELECT OPPO 173 173 K-1 Exp GSO ENERGY SELECT OPPO 3281 2026 K-1 Exp PCCP EQUITY VII, LP 22725 22718 K-1 Exp PCCP EQUITY VIII, LP 5652 5649 K-1 Exp SILVERPEAK CREDIT OPPO 2274 2274 K-1 Exp THE EDGBASTON ASIAN EQ 3100 2974 Office & Supplies 30 30 Postage/Delivery Service 107 107 Registered Agent Fee 125 125 State or Local Filing Fees 235 235 Website Hosting/Support 480 480 PARKING FEES 10735 10735 K-1 Inc/Loss 1150 UNION INVESTORS LLC -634 -634 K-1 Inc/Loss AIR U.S. LIFE FUND III, LP 77177 77177 K-1 Inc/Loss AIR US LIFE FUND IV, LP 1162 1162 K-1 Inc/Loss ALTAIR - PACIFIC COAST CPTL PTNRS EQU 26431 29704 K-1 Inc/Loss ALTAIR DIRECT LENDING FUND, LLC 85 85 K-1 Inc/Loss ALTAIR SENIOR HOUSING FUND (AEW), LLC -53339 -3834 K-1 Inc/Loss ANAGENESIS CAPITAL PARTNERS SBIC FUND 58817 110745 K-1 Inc/Loss BW GAS & CONVENIENCE ONSHORE FUND, LP -42126 -42126 K-1 Inc/Loss ENLIGHTENMENT CAPITAL SOLUTIONS FUND 64777 64777 K-1 Inc/Loss FIRST EAGLE CLO EQUITY FUND I, LP 74756 57584 K-1 Inc/Loss FOURTHSTONE SMALL-CAP FINANCIALS FD L 270 270 K-1 Inc/Loss GRANITE CREEK FLEXCAP II, L.P 84052 84052 K-1 Inc/Loss GSO CAPITAL SOLUTIONS FUND II AIV-1 L -135 -40 K-1 Inc/Loss GSO CAPITAL SOLUTIONS FUND II AIV-2 L 102302 1300 K-1 Inc/Loss GSO CAPITAL SOLUTIONS FUND II LP 1189 1108 K-1 Inc/Loss GSO ENERGY SELECT OPPORTUNITIES FUND 46917 -391 K-1 Inc/Loss GSO ENERGY SELECT OPPORTUNITIES FUND 10185 6289 K-1 Inc/Loss PCCP EQUITY VII, LP -9522 972 K-1 Inc/Loss PCCP EQUITY VIII, LP -11451 394 K-1 Inc/Loss SILVERPEAK CREDIT OPPORTUNITIES OFFSH 163608 163608 K-1 Inc/Loss THE EDGBASTON ASIAN EQUITY TRUST 49168 49168 K-1 Inc/Loss TRINITY CAPITAL FUND III, L.P -47679 -47679 Federal Tax Refund 37273 Foreign Currency Gain 1638 1638 RETURNED GRANT NEXT FISCAL YEAR 8885 Administration of Foundation 29721 29721 Investment Management Services 386250 386250 Website Development 2058 2058 990-PF Estimated Tax for 2020 32700 990-T Extension for 2019 1800 990-T Income Tax for 2019 91871 Foreign Tax Paid 28110 28110 STATE TAXES WITHHELD BY PTSHP 2984 STATE UBTI TAX 2019 38209